Structure-based drug design for TSPO: Challenges and opportunities

Area of Science:

• Biochemistry and Molecular Biology
• Neuroscience
• Pharmacology

Background:

• The translocator protein 18 kDa (TSPO) is a mitochondrial protein involved in neuropathologies and inflammation.
• TSPO is a significant diagnostic and therapeutic target, with various ligand chemotypes developed.
• Existing knowledge of TSPO's structure and function in health and disease remains incomplete.

Purpose of the Study:

• To critically analyze computational methodologies used for modeling TSPO structure and ligand-binding.
• To outline the uses, limitations, and challenges of current computational approaches for TSPO.
• To suggest novel computational strategies for advancing TSPO research.

Main Methods:

• Literature review and critical analysis of computational methods.
• Examination of existing experimental structures of TSPO.
• Discussion of limitations in current modeling techniques.

Main Results:

• Current computational methods for TSPO modeling have significant limitations.
• Understanding TSPO's differential structural and functional features requires improved computational tools.
• There are unexplored opportunities in computational methodologies for TSPO research.

Conclusions:

• Existing computational methods are insufficient for fully characterizing TSPO.
• Advancements in computational approaches are crucial for understanding TSPO in health and disease.
• Novel computational strategies hold promise for enhancing TSPO research and therapeutic development.